StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc (VRTX) income statement

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3031% above fair value
$536.45+2.25 (+0.42%)

Close on Nov 18, 2026Market cap $135.97BP/E 31.2Yield –

See a number that looks wrong?